Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Putra Mandiri Jembar Tbk. (PMJS) Price & Performance

Indofarma Tbk.Trade
Putra Mandiri Jembar Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Putra Mandiri Jembar Tbk. trades at Rp143 (market cap 2.01T, 1.63M 24h volume). The key difference: Putra Mandiri Jembar Tbk. is far larger — about 5.1× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFPMJS
Market Cap
390.51B2.01T
Volume
1.63M
Lot
16.34K
Turnover
235.47M
Average Price
144.09
Value
235.47M
Indicative Equilibrium Price
143
Indicative Equilibrium Volume
678

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
PMJS
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Putra Mandiri Jembar Tbk.

PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.

Read more on PMJS